PubMedCrossRef 25. Valdezate S, Vindel A, Martin-Davila P, Sanchez Del Saz B, Baquero F, Canton R: High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004, 42:693–699.PubMedCrossRef 26. Kaiser S, Biehler K, Jonas D: A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population find more structure. J Bacteriol 2009, 9:2934–2943.CrossRef 27. Denton M, Todd NJ, Kerr KG, Hawkey PM, Littlewood JM: Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and

associated environmental samples. J Clin Microbiol 1998, 36:1953–1958.PubMed 28. Berg G, Roskot N, Smalla K: Genotypic and phenotypic relationships between clinical and environmental isolates of check details Stenotrophomonas

maltophilia . J Clin Microbiol 1999, 37:3594–3600.PubMed 29. Canton R, Valdezate S, Vindel A, Sanchez Del Saz B, Maiz L, Baquero F: Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates. Pediatr Pulmonol 2003, Ilomastat research buy 35:99–107.PubMedCrossRef 30. Gülmez D, Hasçelik G: Stenotrophomonas maltophilia : antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Clin Microbiol Infect 2005, 11:880–886.PubMedCrossRef 31. Schaumann 17-DMAG (Alvespimycin) HCl R, Laurin F, Rodloff AC: Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting. Int J Hyg Environ Health 2008,211(3–4):292–298.PubMedCrossRef 32. Nazik H, Ongen B, Erturan Z, Salcioğlu M: Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Jpn J Infect Dis 2007, 60:82–86.PubMed 33. Marzuillo

C, De Giusti M, Tufi D, Giordano A, Del Cimmuto A, Quattrucci S, Mancini C, Villari P: Molecular characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment. Infect Control Hosp Epidemiol 2009, 30:753–758.PubMedCrossRef 34. Pompilio A, Crocetta V, Pomponio S, Bragonzi A, Holà V, Fiscarelli E, Piccolomini R, Di Bonaventura G: Environmental Stenotrophomonas maltophilia strain is less virulent than clinical strain from cystic fibrosis patient [Abstract]. Clin Microbiol Infect 2010,16(Suppl 2):S590. 35. Pompilio A, Catavitello C, Picciani C, Confalone P, Piccolomini R, Savini V, Fiscarelli E, D’Antonio D, Di Bonaventura G: Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. J Med Microbiol 2010,59(Pt 1):76–81.PubMedCrossRef 36. Begley M, Gahan CGM, Hill C: The interaction between bacteria and bile. FEMS Microbiol Rev 2005, 29:625–651.PubMedCrossRef 37.